Britt Meelby Jensen

Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits. 1 day agoBritt Meelby Jensen born in 1973 has more than 20 years of experience from the life science industry.

View Britt Meelby Jensens professional profile on Relationship Science the database of decision makers.

. Britt Meelby Jensen has served as board member of The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer CEO. From 2019 to. Britt Meelby Jensen born in 1973 has more than 20 years of experience from the life science industry.

Kompetencer og særlige opgaver i bestyrelsen. Britt has over twenty years of experience from the life science industry pharma diagnostics biotech and medtech. Today is World Voice Day an annual event dedicated to the celebration of the phenomenon of voice.

For sin rolle i Atos. Britt Meelby Jensen var den oplagte kandidat. From 2019 Britt Meelby Jensen served as CEO of Swedish Atos Medical until she led the sale of the company to Coloplast in early 2022.

His place at the helm will be taken over by Britt Meelby Jensen who has been a board member of Ambu since 2019 a position she leaves as part of the executive reshuffle. Genvalgt senest i 2021. International Marketing Management Copenhagen Business School 2000 MBA Economics Solvay Business.

Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the. 1 day agoBritt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who. Britt Meelby Jensen CEO Atos Medical.

At Atos Medical we are also devoted to voice. From 2015 to 2019 Britt Meelby Jensen was CEO of Zealand Pharma. Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the new CEO in the transition as needed.

Fra 2015-2019 var Britt Meelby Jensen administrerende direktør for det børsnoterede biotekselskab Zealand Pharma og hun har tidligere også stået i spidsen for Dako og har haft ledende stillinger i Novo Nordisk. After three years at the front of Swedish medtech company Atos Medical Britt Meelby Jensen has set the date for when she will leave the company a press release announces. The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer CEO.

Britt Meelby Jensen is Vice President at Agilent Technologies Inc. RelSci Relationships are individuals Britt Meelby Jensen likely has professional access to. Direktør i Ambu er den rette kandidat til at genskabe tilliden til medicoselskabet efter blandt andet syv nedjusteringer på tre år.

After this interview in December 2018 Britt Meelby Jensen left Zealand Pharma to become the new CEO of Atos Medical. Britt Meelby Jensen har senest været administrerende direktør for Swedish Atos Medical der senere blev solgt til til Coloplast. Britt Meelby Jensen is a Danish citizen.

Britt Meelby Jensen has served as CEO of Atos Medical since 2019 after serving as CEO of Zealand Pharma AS and Dako AS previously. She holds a MSc in International Marketing and Management from Copenhagen Business School and has earned an MBA from Solvay Business School Université Libre de Bruxelles. 10 hours agoBritt Meelby Jensen der torsdag blev udpeget til ny adm.

Jensen previously was Chief Executive Officer at Zealand Pharma A Chief Executive Officer at Atos Medical AB Vice President General Manager at Dako Denmark ApS and Chief Executive Officer for. Britt Meelby Jensen synes godt om dette. International Marketing Management Copenhagen Business School 2000.

Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the new CEO in the transition as needed. The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer. From 2019 Britt Meelby Jensen served as CEO of Swedish Atos Medical until she led the sale.

Competencies and special tasks on the Board. Press Releases One News Page. På valg i 2024.

Sådan lyder vurderingen fra flere analytikere ifølge Finans. 1 day agoBritt Meelby Jensen is the new CEO of Ambu Photo via Atos Medical Ambu today said it has hired Board Member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez effective tomorrow. 1 day agoEffective tomorrow May 20 Juan Jose Gonzalez will no longer be the chief executive of Danish medtech firm Ambu the firm has announced in a press release.

Since Juan Jose Gonzalez joined as CEO in 2019 Ambu has made good. Den verden Danmark vender tilbage til efter Covid-19 er en radikalt. On March 1 2022 the former Zealand Pharma CEO steps back from the position in Atos Medical which Coloplast acquired for EUR 22bn in November.

Furthermore she has in-depth knowledge and understanding of the Novo Group having held various leadership positions between 2002-2013 at Novo Nordisk AS. Trying to get in touch with Britt Meelby Jensen. Hun har en del kredit i markedet bla.

Since Juan Jose Gonzalez joined as CEO in 2019 Ambu has made. For example the establishment of a permanent Life Science office referring to the Danish Minister for Industry Business and Financial Affairs is a step in the right direction says Meelby Jensen. Britt Meelby Jensen is on the board of Novo Holdings An and 6 other companies.

Though Atos Medical is headquartered in Malmo it is a global company with most of the 800 employees spread all over the world so Meelbys new job also involves a lot of traveling something she also looks forward to.

Marketing

Britt Meelby Jensen Is The New Ceo Of Atos Medical Nordic Life Science The Leading Nordic Life Science News Service

Britt Meelby Jensen Crunchbase Person Profile

Britt Meelby Jensen Den Danske Biotekdronning

Equinor Publishes First Tax Contribution Report Equinor Com

Zealand Pharma On Twitter Zealand S Ceo Britt Meelby Jensen Is Mentioned In Labiotech Eu S Article About 15 Successful Women In Biotech Https T Co Em8imknxso Https T Co 3hs9eya65c Twitter